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Abstract
Background: Control of translation allows for rapid adaptation of the cell to stimuli, rather than the slower
transcriptional control. We presume that translational control is an essential process in the control of adipogenesis,
especially in the first hours after hormonal stimulation. 3T3-L1 preadipocytes were cultured to confluency and
adipogenesis was induced by standard protocols using a hormonal cocktail. Cells were harvested before and 6
hours after hormonal induction. mRNAs attached to ribosomes (polysomal mRNAs) were separated from unbound
mRNAs by velocity sedimentation. Pools of polysomal and unbound mRNA fractions were analyzed by microarray
analysis. Changes in relative abundance in unbound and polysomal mRNA pools were calculated to detect putative
changes in translational activity. Changes of expression levels of selected genes were verified by qPCR and Western
blotting.
Results: We identified 43 genes that shifted towards the polysomal fraction (up-regulated) and 2 genes that
shifted towards free mRNA fraction (down-regulated). Interestingly, we found Ghrelin to be down-regulated. Up-
regulated genes comprise factors that are nucleic acid binding (eIF4B, HSF1, IRF6, MYC, POLR2a, RPL18, RPL27a,
RPL6, RPL7a, RPS18, RPSa, TSC22d3), form part of ribosomes (RPL18, RPL27a, RPL6, RPL7a, RPS18, RPSa), act on the
regulation of translation (eIF4B) or transcription (HSF1, IRF6, MYC, TSC22d3). Others act as chaperones (BAG3,
HSPA8, HSP90ab1) or in other metabolic or signals transducing processes.
Conclusions: We conclude that a moderate reorganisation of the functionality of the ribosomal machinery and
translational activity are very important steps for growth and gene expression control in the initial phase of
adipogenesis.
Background
White adipose tissue (WAT) plays an important role in
homeostasis by storing and releasing triglycerides and
by releasing many hormonal factors called adipokines
such as leptin or adiponectin. High caloric intake leads
to the expansion of WAT by an increase of adipocyte
numbers (hyperplasy), by expanding the volume of exist-
ing adipocytes (hypertrophy) or a combination of both
[1]. In order to understand, which mechanisms drive
hypertrophic or hyperplastic obesity, we need to
understand the mechanisms controlling growth and dif-
ferentiation of adipocytes.
Many factors have already been identified, mainly by
RNA analysis, which regulate cell fate and control the
transformation of preadipocytes into mature adipocytes.
This process confers massive changes in the structure of
the cell, which leads to storage of fat and the formation
of fat vacuoles. The orchestrated changes in the struc-
ture of the preadipocyte require tight control of the
involved factors.
An extensively studied model for adipogenesis in vitro
is the mouse embryonic fibroblast cell line 3T3-L1 [2-4].
3T3-L1 cells are grown to confluency and among stimu-
lation with a hormone cocktail consisting of insulin,
dexamethasone and isobutylmethylxanthine (IBMX),
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cells re-enter cell cycle within 24 to 36 h. Two rounds
of cell division are performed after which they perma-
nently withdraw from the cell cycle, begin to accumulate
lipid, and undergo terminal differentiation into mature
adipocytes. Until recently, regulating mechanisms of the
earliest step in the differentiation process are poorly
understood in comparison to later stages of
adipogenesis.
The orchestrated changes in the expression of struc-
tural proteins require changes in the expression and
activity of factors controlling the expression of structural
proteins. Induction of adipogenesis by hormones leads to
the expression of C/EBPb and C/EBPδ within 2 hours
[5], which activate the expression of PPARg and C/EBPa
at low levels. PPARg and C/EBPa activate each others’
expression in a positive feedback loop that promotes and
maintains the differentiated state [6]. The latter proteins
orchestrate the changes in gene expression typical for
mature adipocytes. Besides the C/EBP family and PPARg,
many other factors are known that play a role in adipo-
genesis. Most of these factors are regulated on the tran-
scriptional level and mRNA steady state levels can be
easily measured. However, there is increasing evidence
that proteins, which are controlled at the translational
level, are of uttermost importance for adipogenesis and
other cellular processes. A handful of translationally con-
trolled proteins has been characterized in adipogenesis
up to now. The C/EBP factors C/EBPa and C/EBPb are
regulated at the posttranscriptional level, whereupon var-
ious isoforms arise from a unique mRNA by differential
initiation of translation [7]. In 3T3-L1 cells, high eIF2
and eIF4E activity shifts the ratio of C/EBP isoforms
expression toward more truncated isoforms [7]. An
important factor that controls adipogenesis at the trans-
lational level is HZF [8]. HZF enhances translation of C/
EBPa mRNA by binding to its 3´-untranslated region.
Knock-down of HZF disrupts adipogenesis.
In most cases, translation efficiency is closely related
to ribosomal association of the respective mRNA. The
degree of ribosomal association can be easily measured
by separation of the mRNAs in a sucrose gradient by
velocity sedimentation [9]. The gradient is fractionated,
mRNA is isolated from each fraction and the ratio of
the 28S/18S rRNA is used to determine the fractions
containing free RNA (no ribosomes bound) and polyso-
mal RNA [10]. By use of microarrays, the composition
of the RNA pools can be determined easily [11,12].
We used velocity sedimentation and microarray analy-
sis to identify mRNAs that change in ribosomal associa-
tion during the first 6 hours after hormonal induction of
adipogenesis of 3T3-L1 cells and assessed changes of




Adipogenesis was assessed microscopically by Oil Red O
staining (Additional file 1). In comparison to the fibro-
blastic phenotype of preadipocytes, mature adipocytes´
phenotype is round and cells accumulate lipid droplets
in the cytoplasm. Additionally, adipogenesis was
assessed by the analysis of mRNA steady state levels of
C/EBPb and PPARg by means of q-PCR in total RNA at
time points day 0, 1 and 9. Ct-values were calibrated to
day 0, normalized with bActin, (mean of 3 experiments
with 3 replicates each, n = 9). C/EBPb was up-regulated
3times at day 1 and back to base levels at day 9. PPARg
was up-regulated at day 9, no significant change of
mRNA steady state levels were detected at day 1 (Addi-
tional file 2). These data confirm correct adipogenesis
[13].
Velocity sedimentation and polysome analysis
We analyzed mRNA distribution in samples taken
immediately before (0 h) and 6 hours after hormonal
stimulation (0 h + 6). 13 fractions of 1 ml each were
collected from the top of the ultra centrifuged gradient.
Stability of linear gradients was proved by refractive
index of sucrose concentration (Additional file 3). The
gradients showed high stability in fraction sucrose con-
centration. After RNA isolation, the ratio of 28S to 18S
rRNA was measured to determine the distribution of
free RNA and polysomal RNA. Non-polysomal RNA
shows 28S/18S ratios unequal to two, while polysomal
fractions show 28/18S ratios close to two [10]. Fractions
5, 6 and 7 were pooled and considered as free RNA
(Additional file 4). Fractions 9, 10 and 11 were pooled
and considered as polysomal RNA. Fraction 1 to 4 con-
tained mainly buffer, remaining cell lysate and fat, frac-
tion 12 and 13 contained cell debris. These fractions
were not used for ribosome profiling. Fraction 8 was not
used in order to obtain a clear separation of polysomal
and non-polysomal fractions.
Microarray analysis
Microarray analysis was performed according to stan-
dard protocols in three biological replicates (Agilent
Technologies; Cat. No. G4122F; 41,000 genes repre-
sented) [14]. Expression levels were normalized to the
spike values and the quality control revealed the
expected clustering of fractions into polysomal and non-
polysomal ones as well as clustering of time points (see
methods). Data were submitted to GEO (accession num-
ber GSE29744). We identified 918 up-regulated and 20
down-regulated genes with a false discovery rate (fdr)
<0.05 and with M-value (=log2(fold change)) >1. To
exclude false positives from decreasing total mRNA
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steady state levels (relative increase in polysomal RNA
versus free RNA after induction) only genes with values
of p6 > p0, p6 > np6, np6 < np0, p0 < np0 were included
in the analysis. For the present study, only genes with
M-value > 2 were considered. 43 genes showed highest
abundance in polysomal fractions at time point 6 h after
hormonal induction and were identified as up-regulated
(Table 1 and Additional file 5). Two genes were
Table 1 GenBank accession numbers for mRNAs that are fourfold and greater up- or down-regulated 6 hours after
stimulation of adipogenesis (for further information, e
mRNAs up-regulated 6 hours after stimulation of adipogenesis
AK087631 interferon regulatory factor 6 (IRF6)
NM_009089 polymerase (RNA) II (DNA directed) polypeptide A (POLR2a)
NM_001008233 pleckstrin homology domain containing, family N member 1 (PLEKHN1)
NM_013892 proprotein convertase subtilisin/kexin type 1 inhibitor (PCSK1n)
NM_011975 ribosomal protein L27a (RPL27a)
NM_145625 eukaryotic translation initiation factor 4B (eIF4B)
NM_011830 inosine 5’-phosphate dehydrogenase 2 (IMPDH2)
NM_080420 lactoperoxidase (LPO)
NM_175460 Nicotinamide nucleotide adenylyltransferase 2 (NMNAT2)
NM_011296 ribosomal protein S18 (RPS18)
NM_031165 heat shock protein 8 (HSPA8)
AK129018 sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G (SEMA3g)
NM_133778 family with sequence similarity 131, member A (FAM131a)
NM_026232 solute carrier family 25, member 30 (SLC25a30)
AK006075 RIKEN cDNA 4930558C23 gene (4930558C23RIK)
NM_007926 small inducible cytokine subfamily E, member 1 (SCYE1)
L32836 S-adenosylhomocysteine hydrolase (AHCY)
NM_177354 vasohibin 1 (VASH1)
NM_008302 heat shock protein 90 alpha (cytosolic), class B member 1 (HSP90ab1)
NM_031160 ADP-ribosylation factor-like 4D (ARL4d)
NM_010849 myelocytomatosis oncogene (MYC)
AF024519 TSC22 domain family, member 3 (TSC22d3)
NM_013721 ribosomal protein L7A (RPL7a)
AK159732 solute carrier family 25, member 30 (SLC25a30)
XR_002409 no description
NM_007451 solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 5 (SLC25a5)
NM_145476 TBC1 domain family, member 22a (TBC1d22a)
NM_001077364 TSC22 domain family, member 3 (TSC22d3)
NM_011962 procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 (PLOD3)
AJ250687 BCL2-associated athanogene 3 (BAG3)
NM_009876 cyclin-dependent kinase inhibitor 1C (P57) (CDKN1c)
NM_011468 small proline-rich protein 2A (SPRR2a)
Z49206 heat shock factor 1 (HSF1)
NM_001013830 no description
XM_973351 ribosomal protein S15a pseudogene (GM13253)
NM_009077 ribosomal protein L18 (RPL18)
XR_005114 predicted gene, 675507
NM_011029 ribosomal protein SA (RPSa)
NM_021532 dapper homolog 1, antagonist of beta-catenin (xenopus) (DACT1)
NM_153680 sorting nexin 17 (SNX17)
NM_026144 dehydrodolichyl diphosphate synthase (DHDDS)
NM_011290 ribosomal protein L6 (RPL6)
NM_027652 ethanolaminephosphotransferase 1 (EPT1)
mRNAs down-regulated 6 hours after stimulation of adipogenesis
NM_008331 interferon-induced protein with tetratricopeptide repeats 1 (IFIT1)
NM_021488 ghrelin (GHRL)
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identified as down-regulated with M-values < -2, p6 < p0
and p0 > np0 (Table 1 and Additional file 5). Determina-
tion of unchanged gene expression between (p6-p0) and
(np6-np0) was based on two one-sided tests for equiva-
lence gene-by-gene [15,16] in which a magnitude of 0.2
was chosen for the region of similarity and 27 genes fit
these parameters (Figure 1).
Quantitative Real Time-PCR (q-PCR)
In order to assess up-regulation of genes as determined
by microarray analysis, we chose three up-regulated
genes (RPL27a, eIF4B and IMPDH2) and one gene with
unchanged mRNA (UBE2k/HIP2) for target verification
by q-PCR. The RNA preparation used for q-PCR was
the same as the one used for Agilent 2100 Bioanalyzer-
analysis. q-PCR data confirmed microarray results.
RPL27a was up-regulated 7.4 times in microarray
analysis (MA) (fdr: 2.38E-07), and 13.8 times up-regu-
lated in q-PCR (p-value: 0.0163). eIF4B was 7.2 times
up-regulated in MA (fdr: 4.12E-07) and 8.3 times up-
regulated (p -value: 0.1423) in q-PCR. IMPDH2 was 6
times up-regulated in MA (fdr: 3.26E-07) and 12.2 times
up-regulated (p-value: 0.073) in q-PCR. UBE2k was
neither up nor down-regulated in MA (fdr: 0.013) or q-
PCR. Hence, up-regulation of three randomly chosen
genes was successfully confirmed by q-PCR (Additional
file 6).
Western Blotting
To confirm up-regulation of protein levels of mRNAs
identified in microarray assays and confirmed by q-PCR,
3T3-L1 cells were differentiated for 6 hours and protein
levels were analyzed by Western blotting. We analyzed
protein levels of the three up-regulated proteins eIF4B,
Figure 1 Heatmap for spike-normalized microarray expression data. Columns 1 to 4 show log2 expression data for polysomal (p) and non-
polysomal (np) fractions at two time points (0 h and 6 h after hormonal induction). Column 5 shows log2 fold change M ((p6-np6) - (p0-np0)).
Only genes with fdr <0.05 were selected. Genes were identified as up-regulated (Up; highest expression in polysomal fractions at time point 6 h
after hormonal induction) with M-value > 2, p6 > p0, p6 > np6, np6 < np0, p0 < np0. Genes were identified as down regulated (Down) with M-
value < -2, p6 < p0 and as neither up nor down regulated (Equal) with equivalence test parameter ‘epsilon = 0,2’. High expression levels are
shown in dark grey, low expression levels in white.
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IMPDH2 and RPL27a and the unchanged gene UBE2k
in three biological replicates, each biological replicate
being performed twice. Changes in protein expression
were quantified by densitometry and normalized with
appropriate expression data of bActin (Figure 2). eIF4B
and RPL27a protein levels were 1.4 fold higher (t-test,
p-value < 0.05) at 0 + 6 h than at 0 h. Impdh2 and
UBE2k/HIP2 showed no significant differences in pro-
tein levels between 0 h and 0+ 6 h after hormonal
induction.
Cluster analysis
We used PANTHER DB to classify genes into functional
groups. For 5 of the 43 up-regulated mRNAs, no func-
tion is known. The known genes code for proteins that
are nucleic acid binding - either RNA or DNA - (eIF4B,
HSF1, IRF6, MYC, POLR2a, RPL18, RPL27a, RPL6,
RPL7a, RPS18, RPSa, TSC22d3), form part of ribosomes
(RPL18, RPL27a, RPL6, RPL7a, RPS18, RPSa), act on the
regulation of translation (eIF4B) or transcription (HSF1,
IRF6, MYC, TSC22d3), as chaperones (BAG3, HSPA8,
HSP90ab1), nucleotidyl transferase (NMNAT2,
POLR2a), amino acid transporter (SLC25a5, SLC25a30),
kinase inhibitor (CDKN1c), aminoacyl-tRNA synthetase
(SCYE1), peroxidase (LPO), oxidoreductase (IMPDH2,
LPO, PLOD3), oxygenase (PLOD3) or hydrolase
(AHCY, TBC1d22a) and peptide hormone (GHRL).
PANTHER informations are shown in Additional file 7.
Discussion
We analyzed the changes in the abundance of mRNAs
in free or ribosome bound fractions from velocity sedi-
mentation during the first hours of adipogenesis in 3T3-
L1 mouse cells. We identified 43 genes that were signifi-
cantly increased in the polysomal fraction at T6, and
two genes with lower abundance (Table 1) 6 hours after
the induction of adipogenesis by administration of a
hormone cocktail to the confluent cell culture. We con-
firmed MA data by q-PCR of three randomly chosen
up-regulated genes. Finally, we analyzed protein levels of
the three up-regulated genes eIF4B, IMPDH2 and
RPL27a and the unchanged gene UBE2k/HIP2 (Figure
2). In Western blots, IMPDH2 protein levels were
unchanged. It is subject to further investigation, if ribo-
somes on IMPDH2 mRNA are stalled, protein levels
increase later in the course of adipogenesis or if other
mechanisms are employed to keep the protein levels
unchanged. eIF4B and RPL27a levels were confirmed to
be up-regulated and we assume that as a general rule,
changes in translational activity are predicted by changes
of ribosomal association as has been demonstrated
before [17].
There are several studies of transcriptional changes
during adipogenesis and many factors have been identi-
fied that play an important role in this process. Burton
et al., 2002 identified 286 clones with a greater than
fivefold deviation of expression during the first 24 hours
Figure 2 Western blot results. 3T3-L1 cells were differentiated with insulin, dexamethasone and IBMX. Protein was isolated from whole cell
extracts 0 h (T0) and 6 h (T6) after hormonal induction. 30 μg of each sample was subjected to Western blot analysis for eIF4B, IMPDH2, RPL27a
and UBE2k/HIP2 expression. Changes in protein expression were quantified by densitometry and normalized with appropriate expression data of
bActin. The values represent the average of three independent experiments, and the asterisk denotes a p-value < 0.05. eIF4B and RPL27a protein
expression is 1.4 fold higher (p-value < 0.05) at T6 than time point T0. IMPDH2 and UBE2k/HIP2 show no significant differences in protein
expression between T0 and T6.
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of adipogenesis [5]. In our study, none of these factors
showed changes greater than fourfold with the exception
of c-Myc. We conclude that analysis of translational
activity is important for a full understanding of the pro-
cesses controlling adipogenesis.
In the last few years, interest increased in the
dynamics of the proteome and there is a handful of stu-
dies in man and mouse [18-24] about changes of the
proteome, comparing preadipocytes and adipocytes in
tissues, or later stages of adipogenesis. Here, we report
changes as soon as 6 hours after hormonal induction of
adipogenesis, a timepoint, at which clonal expansion of
3T3-L1 cells is induced and expression of mitotic and
adipogenic genes is initiated.
3T3-L1 adipocytes are grown to confluency and upon
stimulation with a hormone cocktail (insulin, dexa-
methasone and IBMX), post-confluent G0 cells reenter
one to two rounds of cell-cylce called mitotic clonal
expansion (MCE) [25]. It has been proposed that MCE
might facilitate the DNA remodeling for the adipogen-
esis gene expression program [2]. As 3T3-L1 cells reen-
ter cell cycle by passing from G0 to G1 phase, it might
be expected that the translation machinery is activated
after hormonal stimulation. In fact, we detected a shift
of mRNAs toward the higher molecular weight polyso-
mal fractions, mostly derived from a general activation
of gene expression. Expression of ribosomal proteins,
ribosome assembly proteins and ribosomal RNA (rRNA)
are up-regulated in mitotic active cells. Hence it is not
surprising that ribosomal proteins (RP) are prominent
among the up-regulated proteins (compare Table 1).
Additionally, for some RPs, extraribosomal functions
have been demonstrated. Many of these extraribosomal
functions can be attributed to the regulation of cell
cycle and for several RPs a role in cancer, promotion of
cell growth or differentiation has been shown [26].
Some of these known extraribosomal functions might
well explain the role of the RPs in the early phase of
adipogenesis (Figure 3).
RPL6 was initially identified as up-regulated in gastric
multidrug-resistant cancer cells [27] and was shown to
protect gastric cancer cells from drug-induced apoptosis.
Furthermore, RPL6 over-expression promotes G1 to S
phase transition of gastric cancer cells and promotes
cell growth [28] (Figure 3). RPL7a interacts with the
human thyroid hormone receptor and inhibits transacti-
vation. Thyroid hormone signalling stimulates adipogen-
esis [29,30] and up-regulation of RPL7a might
participate in mitotic control. RPL18 was shown to inhi-
bit autophosphorylation of the double-stranded RNA-
activated protein kinase (PKR) and PKR mediated phos-
phorylation of the translation initiation factor eIF2a.
Over-expression of RPL18 reduced eIF2a phosphoryla-
tion and stimulated translation of a reporter gene in
vivo [31]. Over-expression of RPL18 is thought to pro-
mote protein synthesis and cell growth through inhibi-
tion of PKR activity [31], which also might hold true for
adipogenesis. A polymorphism in the promoter region
of the RPL27a gene was associated with meat marbling
(accumulation of intramuscular fat) in Japanese Black
beef cattle [32]. Furthermore, RPL27a is ubiquitinated in
a cell-cycle specific manner, leading to increased transla-
tional efficiency of the ribosomes [33].
RPSa, which was up-regulated in our study, was pre-
viously known as 37-kDa laminin receptor precursor/67-
kDa laminin receptor (LRP/LR). It has a number of
functions depending on its subcellular localisation. In
the nucleus, RPSa binds to DNA by histone binding, in
the cytoplasm it is associated with the 40S small riboso-
mal subunit and at the cell surface it acts as a receptor
for various components [34]. It confers an anti-obesity
effect when stimulated by the green tea catechin EGCG
[35]. Interestingly, RPSa inhibits insulin stimulation of
3T3-L1 mitogenesis and EGCG inhibited differentiation
of preadipocytes to adipocytes [36].
Most of the RPs up-regulated immediately after hor-
monal induction were shown to stimulate cell cycle
which is concordant with the fact that 3T3-L1 cells
undergo mitosis after stimulation. Translational control
allows for rapid changes of protein redundancy and it
may be speculated that proteins that initiate MCE and
reprogramming of gene expression are regulated at the
translational level. Therefore we suggest that the rapid
increase of L6, L7a, L18, L27a, Sa, and S18 may reflect
their importance of adipogenesis control in 3T3-L1 cells.
Higher translation rates require transport of amino
acids, and we detected up-regulation of the amino acid
transporters SLC25a5 and SLC25a30. Higher translation
rates also lead to increased misfolding of nascent poly-
peptide chains. Up-regulation of chaperones in transla-
tion promoting conditions has been described before
and was also observed in our study (BAG3, HSPA8,
HSP90ab1).
The PI3K-AKT-mTOR pathway, which is stimulated
by insulin, has been identified to be essential for many
cellular processes (reviewed in [37]). mTORC1 is a pro-
tein complex containing mTOR (mammalian target of
rapamycin) and raptor. mTORC1 activates S6K1, a
kinase that promotes protein synthesis and cell growth
by phosphorylation of multiple substrates including
components of translation initiation or elongation such
as ribosomal protein S6, eIF4B and eukaryotic elonga-
tion factor 2 kinase [38]. One target of this pathway is
eIF4B (Figure 4) (reviewed in [39]). It was suggested
that phosphorylation of eIF4B by S6 kinases, which are
regulated by mTOR, stimulates its function. Indeed, this
phosphorylation event favors recruitment of eIF4B into
complexes with eIF3, which promotes the recruitment
Fromm-Dornieden et al. BMC Molecular Biology 2012, 13:9
http://www.biomedcentral.com/1471-2199/13/9
Page 6 of 12
of ribosomes to the 5´end of the message (reviewed in
[40]). eIF4B, which was up-regulated in our study, sti-
mulates the RNA helicase activity of eIF4A in unwind-
ing secondary structures in the 5´-untranslated regions
(5´-UTR) of mRNAs [41,42]. By knock-down of eIF4B,
selective reduction of translation was observed for
mRNAs harboring strong to moderate secondary struc-
tures in their 5´-UTRs. These mRNAs code for proteins
that function in cell proliferation (e.g. CDC25C, c-MYC)
or cell survival (e.g. BCL-2). Silencing of eIF4B also
leads to decreased proliferation rates and caspase-depen-
dent apoptosis: eIF4B is required for cell proliferation
and survival by regulating the translation of proliferative
and prosurvival mRNAs [43]. PPARg expression is sti-
mulated in response to mTORC1 [44]. PPARg is a key
adipogenic factor and exogenous expression is sufficient
to induce adipogenesis. Zhang et al., 2009 discuss the
possibility that AKT and mTORC1 facilitate adipogen-
esis by up-regulation of PPARg via regulation of FOXO1
[44]. However, they do not discuss the activation of
eIF4B upon mTORC1 activation with subsequent
changes in the preference of ribosomes for certain
mRNAs. We think that regulation of C/EBPa could pos-
sibly be explained by up-regulation of eIF4b activity, as
members of the C/EBP family are regulated at the trans-
lational level (Figure 4).
Microarray results of polysomal fractions from 3T3-L1
cell lysate (6 h after hormonal induction) show up-regu-
lation of eIF4B and MYC (arrow head on top) and
down-regulation of Ghrelin (arrow head below). IR,
insulin receptor; Pol I/II/III, RNA polymerase I/II/III
c-MYC over-expression in cycling cells has been
reported to block exit from the cell cycle, accelerate cell
division, and increase cell size (reviewed in [45]). When
c-MYC levels are high, 3T3-L1 adipoblasts are locked in
a proliferation-competent state and normal differentia-
tion can not be activated. Persisting high levels of c-
MYC can inhibit the expression of genes that promote
adipogenesis namely C/EBPa and PPARg2 and therefore
prevent terminal differentiation of preadipocytes to
Figure 3 Ribosomal and extraribosomal functions of the ribosomal proteins up-regulated in this study. Microarray results of polysomal
fractions from 3T3-L1 cell lysate (6 h after hormonal induction) show that that ribosomal proteins (RP) are prominent among the up-regulated
genes. For some RPs, extraribosomal functions have been demonstrated. In the nucleus, RPSa binds to DNA by histone binding, in the
cytoplasm it is associated with the 40S small ribosomal subunit and at the cell surface it acts as a receptor for various components [34]. RPL6
over-expression promotes G1 to S phase transition of gastric cancer cells and promotes cell growth [28]. RPL7a interacts with the human thyroid
hormone receptor and inhibits transactivation. Hyperthyroidism favours osteosarcoma cell growth and down-regulation of RPL7a might enhance
sensitivity to TR and disrupt growth control [61]. RPL18 was shown to inhibit autophosphorylation of the double-stranded RNA-activated protein
kinase (PKR) and PKR mediated phosphorylation of the translation initiation factor eIF2a. Over-expression of RPL18 reduced eIF2a
phosphorylation and stimulated translation of a reporter gene in vivo [31]. A polymorphism in the promoter region of the RPL27a gene was
associated with meat marbling in Japanese Black beef cattle [32]. These known extraribosomal functions might be important in early
adipogenesis. Additionally an enhanced amount of RPs promotes an increase in translation process of adipocyte specific genes. In the beginning
of translational process, the 43S ribosomal subunit scans mRNAs for start codons. Strong secondary structures inhibit processing of the complex
on the mRNAs. eIF4B increases the helicases activity of the complex and allows translation mRNAs with strong secondary structures in the 5´UTR.
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mature adipocytes [46,47]. In microarray analysis, c-
MYC was up-regulated in 3T3-L1 cells several hours
after hormonal induction in a study by Burton et al.,
2002 [5] and at day 2 of differentiation in a study by
Kim et al., 2007 [48]. c-MYC is an important regulator
of ribogenesis, as it activates Pol I, Pol II and Pol III
leading to activation of expression of rRNA, tRNA, ribo-
somal proteins, initiation factors of translation and other
cell cycle relevant genes [49]. Therefore, c-MYC activa-
tion might be important for activation of the translation
apparatus at the entry of 3T3-L1 cells into G1.
In our study, two genes were down-regulated: IFIT1
and ghrelin/obestatin prepropeptide (referred to as
Ghrelin). The members of the IFIT gene family are
silent in most cell types, but are activated by e.g. inter-
ferons [50]. IFIT proteins are considered silencers of
translation and down-regulation might be another factor
of translation stimulation.
Ghrelin has been described as a pro-adipogenic factor
released by the gut and is involved in control of food
intake, energy metabolism and cytokine secretion
(reviewed in [51]). Treatment of 3T3-L1 preadipocytes
with Ghrelin significantly increases the mRNA levels of
c-MYC, and induces the transition from G1 to S [52].
As a supplement in media, Ghrelin promotes the prolif-
eration and differentiation of 3T3-L1 preadipocytes by
increasing the mRNA levels of PPARg and C/EBPa [52]
(Figure 4). Ghrelin mRNA over-expressing 3T3-L1 cells,
on the other hand, demonstrated significantly attenuated
differentiation of preadipocytes into adipocytes [53]. In
the recent study we found Ghrelin ~ 6 times down-
regulated in polysomal fractions of 3T3-L1 cells six
hours after hormonal induction. Down-regulation of
Ghrelin levels in the early phase of adipogenesis fits the
known facts indicating a role of decreased endogenous
Ghrelin levels in promoting adipogenesis.
Conclusions
We have analyzed changes in translational control at 6
hours after induction of adipogenesis in 3T3-L1 preadi-
pocytes and detected 43 translationally up-regulated and
two down-regulated mRNAs with a minimal change of
Figure 4 Schematic overview of the pathway controlling translational changes in adipogenesis. The PI3K/AKT/mTORC1 pathway, which is
stimulated by insulin, leads to activation of eIF4B, which changes preferences in translation activity [38]. Regulation of C/EBPa could possibly be
explained by up-regulation of eIF4b activity, as members of the C/EBP family are regulated at the translational level (dashed line). Additionally an
increase in translation of adipogenesis genes mediated by eIF4B is thinkable (dashed line). c-MYC over-expression in cycling cells has been
reported to block exit from the cell cycle, accelerate cell division, and increase cell size (reviewed in [45]). When c-MYC levels are high, 3T3-L1
adipoblasts are locked in a proliferation-competent state and normal differentiation can not be activated. Persisting high levels of c-MYC can
inhibit the expression of genes that promote adipogenesis namely C/EBPa and PPARg2 and therefore prevent terminal differentiation of
preadipocytes to mature adipocytes [46,47]. c-MYC is an important regulator of ribogenesis, as it activates Pol I, Pol II and Pol III [49]. As a
supplement in media, Ghrelin promotes the proliferation and differentiation of 3T3-L1 preadipocytes by increasing the mRNA levels of PPARg
and C/EBPa [52]. Ghrelin mRNA over-expressing 3T3-L1 cells, on the other hand, demonstrated significantly attenuated differentiation of
preadipocytes into adipocytes [53]. Down-regulation of Ghrelin levels in the early phase of adipogenesis fits the known facts indicating a role of
decreased endogenous Ghrelin levels in promoting adipogenesis).
Fromm-Dornieden et al. BMC Molecular Biology 2012, 13:9
http://www.biomedcentral.com/1471-2199/13/9
Page 8 of 12
4 fold. The alternatively regulated mRNAs play roles in
cell cycle control, control of transcription, control of
translation, energy supply, protein folding, amino acid
transport and other cellular processes. A large number
of RPs is up-regulated in the first hours of adipogenesis.
Many RPs play a special role in cell cycle regulation and
expression control of genes and mRNAs that are
required for the differentiation process. Most of the
nucleic acid binding factors we detected bind to RNA
and play a role for ribosome function or translation con-
trol. We conclude that after stimulation of adipogenesis,
translation control changes and forms a new layer of
control which might be, at least in part, self-regulating.
The changes in translation might come from changed
properties of ribosomes in response to hormonal stimu-
lation and from increased eIF4b activity. Further analysis
of how protein levels of adipogenic genes are controlled
will deepen our understanding of the complex steps
during the initiation of adipogenesis and help further to
develop strategies to inhibit fat cell accumulation.
Methods
Cells
3T3-L1 cells were ordered from HPACC and cultured in
Dulbecco’s modified Eagle’s medium (DMEM; PAN)
supplemented with 10% newborn bovine serum
(c·c·pro), 25 mM HEPES (PAN) and 1% antibiotics
(Penicillin/Streptomycin, c·c·pro) in 5% CO2 at 37°C.
Absence of Mycoplasm was assessed by DAPI method
on a regular basis. For differentiation, 3T3-L1 cells were
cultured to confluence (day −2) and exposed to the dif-
ferentiation mixture (DMEM, 10% fetal bovine serum,
25 mM HEPES, 1% antibiotics, 0.5 mM isobutylmethyl-
xanthine, 1 μM dexamethasone, 5 μg/ml insulin; all
from Sigma) two days later (day 0). After 48 hrs, med-
ium was replaced by DMEM containing 10% fetal
bovine serum, 25 mM HEPES, 1% antibiotics and 5 μg/
ml insulin. At day 5, this medium was changed to med-
ium without insulin and replaced at day 7 by fresh med-
ium. The success of adipogenesis was proved by Oil Red
O (Sigma) staining (Additional file 1) and analysis of
mRNA steady state levels of well known adipogenesis
factors (C/EBPb and PPARg) with q-PCR (Power SYBR®
Green PCR Master Mix, ABI) [13], normalized with
bActin. Three biological replicates were used for further
analysis (Additional file 2).
Velocity sedimentation and polysome analysis
3T3-L1 cells were harvested at day 0 (T0, without hor-
monal induction) and 6 h after hormonal induction
(T6). Cells were lysed mechanically in polysome buffer
(300 mM KCl, 5 mM MgCl2, 10 mM PIPES pH 7.4),
0.5% NP40, 12U RNase Inhibitor (Roche) and 100 ng/ml
Cycloheximide (Sigma). To separate polysomal RNA
from non-polysomal RNA, linear sucrose gradients were
built from polysome buffer with 0% to 50% sucrose con-
centration. Stability of linear gradients was proved with
a refractometer (Type MHRB 90; Müller). Cell lysate
was cooled on ice and layered onto gradients which
were subjected to centrifugation at 37,500 rpm (28,000
× g) in a SW40 rotor (Beckmann Optima™ L Prepara-
tive Ultracentrifuge) at 4°C for 120 min. 13 fractions of
1 ml were collected from the top of the gradient. From
600 μl of each fraction RNA was isolated and the ratio
of 28S to 18S rRNA was measured to obtain the poly-
some profile on Agilent 2100 Bioanalyzer [10]. Based on
the polysome profile, 200 μl of each selected gradient
fraction were used for pooling of samples into polyso-
mal/non-polysomal parts (Additional file 4). An appro-
priate amount of viral RNA (One Color Spike-In Kit;
Agilent Technologies; Cat. No. 5188-5279) for 1 μg of
test-RNA was added to allow for the comparison of
relative RNA amounts in later analysis. Total RNA was
extracted by using the Trizol Reagent (Invitrogen). Sub-
sequently to RNA isolation, a DNase I digest was per-
formed. RNA were checked for quantity, purity and
integrity of the 18S and 28S ribosomal bands by capil-
lary electrophoresis using the Agilent 2100 bioanalyzer
and the NanoDropND-1000 UV-VIS Spectrophotometer
version 3.2.1.
Microarray analysis
Microarrays were done using the “Low RNA Input lin-
ear Amplification Kit Plus, One Color” protocol (Agilent
Technologies, Inc. 2007; Cat. N°: 5188-5339) following
the manufacturer’s standard protocol. Global gene
expression analysis was applied in triplicates using
mouse expression arrays (Agilent Technologies; Cat. No.
G4122F; 41,000 genes represented). Quantity and effi-
ciency of the labeled amplified cRNA were determined
using the NanoDrop ND-1000 UV-VIS Spectrophot-
ometer version 3.2.1. The hybridizations were performed
for 17 hours at 10 rpm and 65°C in the Hybridization
Oven (Agilent). Washing and staining of the arrays were
done according to the manufacturer’s recommendation.
Cy3 intensities were detected by one-color scanning
using an Agilent DNA microarray scanner (G2505B) at
5 micron resolution. Scanned image files were visually
inspected for artefacts and then analyzed [14].
Statistics
Total translation activity was calculated comparing
mRNA content of free mRNA fractions versus polyso-
mal fractions using one-sided t-test.
For MA analysis, quality control, normalisation and
analysis of differentially expressed genes was performed
using the software R [54]. The first step of microarray
analysis focused on quality control including correlation
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investigation, hierarchical clustering and principal com-
ponent analysis. Normalisation was based on the spike-
ins, relating expression data to their respective values
while preserving the range of data. With regard to dif-
ferential expression we were interested in significant dif-
ferences between the time group fold changes of the
polysomal (p6-p0) and non-polysomal (np6-np0 ) frac-
tion, where p6 (p0) denotes the log2 signal intensity of
polysomal RNA at day 0 + 6 h (+0 h), and analogously
np marks the non-polysomal fraction. To detect those
differences the empirical Bayes statistic of the limma
package [55] was applied implying amoderated gene-by-
gene t-test followed by p-value adjustment via multiple
testing correction according to the Benjamini-Hochberg
method [56]. Clustering of the expression profiles as
well as sorting into functional and structural groups was
done with PantherDB [57]. Information about candidate
genes was collected in PubMed searches. Data were sub-
mitted to GEO (accession number GSE29744).
Quantitative Real Time-PCR (q-PCR)
RNA (300 ng/20 μl) was reverse-transcribed using the
High Capacity cDNA Reverse Transcription Kit (ABI). 1
μl of the RT reaction mixture was used for quantitative
PCR. Primers to amplify eIF4B, IMPDH2, RPL27a,
UBE2k/HIP2, UCP2 and bActin were purchased from
Sigma Aldrich. q-PCRs were performed with 2x Power
Sybr Green Mastermix (ABI) and Mx4000™ Multiplex
Quantitative PCR System (Stratagene), all samples were
assayed in triplicate. Data was analysed using the ΔΔCT
method with normalizers HIP2, UCP2 and bActin [58].
The resulting ΔΔCT values per replicate are interpreta-
ble as the aforementioned fold change of time ratios
between fraction groups. One sample t-tests were con-
ducted per gene to test whether the mean of the repli-
cates differs significantly from zero. Above that an
analysis of variance was applied to a linear model of the
ΔCT values to treat influences of time and fraction
groups separately [59] (Additional file 6).
Western Blotting
Total protein from 3T3-L1 cells at time points T0 and T6
was extracted with protein extraction buffer (50 mM
NaF, 50 mM Tris HCl, 5 mM NaPPi, 150 mM NaCl, 1%
NP-40, 1 mM Na3VO4 and 1 mM EDTA). For each sam-
ple, 30 μg protein was denatured in Laemmli Buffer for 5
min at 95°C. Proteins were separated by SDS-PAGE and
transferred to PVDF membrane (Millipore) using a tank
blot system (Bio-Rad). The membrane was blocked for 1
h in blocking buffer (5% skim milk powder in PBS). After
washing three times for 15 min in PBS, the membrane
was incubated for 30 min at room temperature with poly-
clonal antibody against bActin (ab75186; Abcam) in a
dilution 1:15,000 in milk (PBS, 2% skim milk powder,
10% fetal bovine serum). The membrane was washed
again and incubated with either polyclonal antibodies
against eIF4B (ab59300, 1: 2,000), IMPDH2 (ab75790,
1:1,000), UBE2k/HIP2 (ab82950, 1:1,000) or RPL27a
(ab74731, 1:1,300) over night at 4°C and afterwards 1 h at
room temperature. Goat polyclonal anti-rabbit IgG con-
jugated with horseradish peroxidase (ab6721, Abcam)
was added to the membrane after washing and incubated
for 90 min at room temperature. Washed membrane was
incubated in Luminata Classico Chemiluminescence
Detection Reagent (Millipore) for 2 min and exposed to
photo film (ECL, Amersham Biosciences). Changes in
protein expression were quantified by densitometry with
Image J and normalized with appropriate expression data
of bActin. For each of the three biological and two tech-
nical replicates per gene the normalized value for time
point 6 was related to the one of time point 0. The result-
ing three ratios per technical replicate were averaged
leading to one value per biological replicate. As the
Image J measurement itself was additionally repeated
threefold, the aforementioned procedure was applied
three times and the mean was taken per biological repli-
cate which finally lead to one averaged value per biologi-
cal replicate. One sample t-tests were conducted per
gene to test whether the mean of those 3 values differs
significantly from one (Figure 2).
Additional material
Additional file 1: Microscopical control of adipogenesis. In
comparison to the fibroblastic phenotype of 3T3-L1 preadipocytes (left
picture), mature adipocytes´ phenotype (right picture) is round and cells
accumulate lipid droplets in the cytoplasm. 3T3-L1 cells two days before
hormonal induction (left picture) were stained with Coomassie blue. Cells
nine days after hormonal induction (right picture) were stained with Oil
Red O (400× magnification).
Additional file 2: Molecular control of adipogenesis. Analysis of
mRNA steady state levels of C/EBPb (empty boxes) and PPARg (filled
boxes) by means of q-PCR in total RNA at time points 0, 0 + 6 h and 9
days. Ct-values were calibrated to day 0, normalized with bActin, (mean
of 3 experiments with 3 replicates each, n = 9). C/EBPb was up-regulated
3times at 0 + 6 h and back to base levels at day 9. PPARg was up-
regulated at day 9, no significant change of mRNA steady state levels
were detected at day 0 + 6 h. Standard deviations are shown by error
bars.
Additional file 3: Control of stability of gradients. Stability of 14 linear
gradients was proved with a refractometer. Gradient fractions were
collected from top of gradient and percentage of sucrose content was
measured. Standard deviations are shown by error bars.
Additional file 4: Sucrose gradient analysis. Polysomal RNA (28S/18S
ratio ~ 2) was separated from non-polysomal RNA (28S/18S ratio ≠2) by
sucrose gradient centrifugation. Ratio of 18S and 28S rRNA was
measured to obtain the polysome profile on Agilent 2100 Bioanalyzer.
Fractions 5 to 7 contain non-polysomal RNA and fractions 9 to 11
polysomal RNA.
Additional file 5: Further information to Table 1. Gene functions,
GenBank accession numbers and fold change for mRNAs that are
fourfold and greater up- or down-regulated 6 hours after stimulation of
adipogenesis.
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Additional file 6: Heatmap forhousekeeper-normalized PCR data.
Column 1 to 4 shows housekeeper-normalized values for polysomal (p)
and non-polysomal (np) fractions at two time points (0 h and 6 h after
hormonal induction). Column 5 shows fraction to time ratio (log; (p6-np6)
- (p0-np0)).
Additional file 7: Results of Cluster analysis by PANTHER DB. This
Table contains the name of the PANTHER classification category, the
genes that map to the respective category, the expected number of
genes in the respective category based on the reference genome, plus
or minus signs indicating over- or under-representation of the respective
category in the experiment and finally the p-values determined by the
binomial statistic according to [60].
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